changing course and improving dismal outcomes in lung cancer: 2022 esmo florida
Published 1 year ago • 33 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
0:30
emerging data on immunotherapies and tyrosine kinase inhibitors in lung cancer: 2022 esmo florida
-
0:39
opportunities for potential cure in non-metastatic non-small cell lung cancer: 2022 esmo florida
-
0:51
“moving the needle” in the metastatic breast cancer setting: 2022 esmo florida
-
2:54
minimally invasive approaches and enhancing surgical options for gastric cancer: 2022 esmo florida
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
10:09
esmo 2020 expert video report on long term ici outcomes in lung cancer
-
3:35
#esmo22 highlights on actionable inflammatory axis for air pollution induced nsclc
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
16:14
esmo 2020 gabriela fernandes talk: lung cancer diagnostic test needs: perspective from a thoracic
-
27:41
lung cancer update | 2022 metro denver oncology nursing society conference
-
1:54
esmo preceptorships – the christie lung cancer preceptorship course
-
5:50
#esmo21 expert video report on novelties in metastatic nsclc
-
1:08:14
advances in diagnosis and treatment of lung cancer
-
22:53
paradigm changes in the perioperative setting for non-small cell lung cancer - karen reckamp, md
-
33:39
local lung cancer | 2022 oneoncology conference
-
1:52
esmo 2022 highlights in head and neck cancer
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing